Injectable Drug Delivery Technology Market Size - Global Industry Share, Analysis, Trends and Forecast 2022 - 2030

CHAPTER 1. Industry Overview of Injectable Drug Delivery Technology Market

1.1. Definition and Scope

1.1.1. Definition of Injectable Drug Delivery Technology

1.1.2. Market Segmentation

1.1.3. Years Considered for the Study

1.1.4. Assumptions and Acronyms Used

1.1.4.1. Market Assumptions and Market Forecast

1.1.4.2. Acronyms Used in Global Injectable Drug Delivery Technology Market

1.2. Summary

1.2.1. Executive Summary 

1.2.2. Injectable Drug Delivery Technology Market By Formulation

1.2.3. Injectable Drug Delivery Technology Market By Device Type

1.2.4. Injectable Drug Delivery Technology Market By Mode Of Delivery

1.2.5. Injectable Drug Delivery Technology Market By Application

1.2.6. Injectable Drug Delivery Technology Market By Region

CHAPTER 2. Research Approach

2.1. Methodology 

2.1.1. Research Programs

2.1.2. Market Size Estimation

2.1.3. Market Breakdown and Data Triangulation

2.2. Data Source

2.2.1. Secondary Sources

2.2.2. Primary Sources

CHAPTER 3. Market Dynamics And Competition Analysis

3.1. Market Drivers

3.1.1. Driver 1

3.1.2. Driver 2

3.2. Restraints and Challenges

3.2.1. Restraint 1

3.2.2. Restraint 2

3.3. Growth Opportunities

3.3.1. Opportunity 1

3.3.2. Opportunity 2 

3.4. Porter’s Five Forces Analysis

3.4.1. Bargaining Power of Suppliers

3.4.2. Bargaining Power of Buyers

3.4.3. Threat of Substitute

3.4.4. Threat of New Entrants

3.4.5. Degree of Competition

3.5. Market Concentration Ratio and Market Maturity Analysis of Injectable Drug Delivery Technology Market

3.5.1. Go To Market Strategy

3.5.1.1. Introduction

3.5.1.2. Growth

3.5.1.3. Maturity

3.5.1.4. Saturation

3.5.1.5. Possible Development

3.6. Technological Roadmap for Injectable Drug Delivery Technology Market

3.7. Value Chain Analysis

3.7.1. List of Key Manufacturers 

3.7.2. List of Customers

3.7.3. Level of Integration

3.8. Cost Structure Analysis

3.8.1. Price Trend of Key Raw Materials

3.8.2. Raw Material Suppliers

3.8.3. Proportion of Manufacturing Cost Structure

3.8.3.1. Raw Material

3.8.3.2. Labor Cost

3.8.3.3. Manufacturing Expense

3.9. Regulatory Compliance

3.10. Competitive Landscape, 2021

3.10.1. Player Positioning Analysis

3.10.2. Key Strategies Adopted By Leading Players

CHAPTER 4. Manufacturing Plant Analysis

4.1. Manufacturing Plant Location and Establish Date of Major Manufacturers in 2021

4.2. R&D Status of Major Manufacturers in 2021

CHAPTER 5. Injectable Drug Delivery Technology Market By Formulation

5.1. Introduction

5.2. Injectable Drug Delivery Technology Revenue By Formulation

5.2.1. Injectable Drug Delivery Technology Revenue (USD Billion) and Forecast, By Formulation, 2018-2030

5.2.2. Nanoparticles

5.2.2.1. Nanoparticles Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

5.2.3. Liposomes

5.2.3.1. Liposomes Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

5.2.4. Microspheres

5.2.4.1. Microspheres Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

5.2.5. Others

5.2.5.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

CHAPTER 6. Injectable Drug Delivery Technology Market By Device Type

6.1. Introduction

6.2. Injectable Drug Delivery Technology Revenue By Device Type

6.2.1. Injectable Drug Delivery Technology Revenue (USD Billion) and Forecast, By Device Type, 2018-2030

6.2.2. Needle Free Injectors

6.2.2.1. Needle Free Injectors Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

6.2.3. Reusable Needles

6.2.3.1. Reusable Needles Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

6.2.4. Pre-Filled Syringes

6.2.4.1. Pre-Filled Syringes Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

6.2.5. Auto Injectors

6.2.5.1. Auto Injectors Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

6.2.6. Pen Needle

6.2.6.1. Pen Needle Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

6.2.7. Disposable Syringes

6.2.7.1. Disposable Syringes Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

6.2.8. Others

6.2.8.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

CHAPTER 7. Injectable Drug Delivery Technology Market By Mode Of Delivery

7.1. Introduction

7.2. Injectable Drug Delivery Technology Revenue By Mode Of Delivery

7.2.1. Injectable Drug Delivery Technology Revenue (USD Billion) and Forecast, By Mode Of Delivery, 2018-2030

7.2.2. Intravenous

7.2.2.1. Intravenous Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

7.2.3. Intraperitoneal

7.2.3.1. Intraperitoneal Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

7.2.4. Intramuscular

7.2.4.1. Intramuscular Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

7.2.5. Subcutaneous

7.2.5.1. Subcutaneous Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

7.2.6. Others

7.2.6.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

CHAPTER 8. Injectable Drug Delivery Technology Market By Application

8.1. Introduction

8.2. Injectable Drug Delivery Technology Revenue By Application

8.2.1. Injectable Drug Delivery Technology Revenue (USD Billion) and Forecast, By Application, 2018-2030

8.2.2. Oncology

8.2.2.1. Oncology Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

8.2.3. Orphan Diseases

8.2.3.1. Orphan Diseases Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

8.2.4. Auto-Immune Disease

8.2.4.1. Auto-Immune Disease Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

8.2.5. Others

8.2.5.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

CHAPTER 9. North America Injectable Drug Delivery Technology Market By Country 

9.1. North America Injectable Drug Delivery Technology Market Overview

9.2. U.S.

9.2.1. U.S. Injectable Drug Delivery Technology Revenue (USD Billion) and Forecast By Formulation, 2018-2030

9.2.2. U.S. Injectable Drug Delivery Technology Revenue (USD Billion) and Forecast By Device Type, 2018-2030

9.2.3. U.S. Injectable Drug Delivery Technology Revenue (USD Billion) and Forecast By Mode Of Delivery, 2018-2030

9.2.4. U.S. Injectable Drug Delivery Technology Revenue (USD Billion) and Forecast By Application, 2018-2030

9.3. Canada

9.3.1. Canada Injectable Drug Delivery Technology Revenue (USD Billion) and Forecast By Formulation, 2018-2030

9.3.2. Canada Injectable Drug Delivery Technology Revenue (USD Billion) and Forecast By Device Type, 2018-2030

9.3.3. Canada Injectable Drug Delivery Technology Revenue (USD Billion) and Forecast By Mode Of Delivery, 2018-2030

9.3.4. Canada Injectable Drug Delivery Technology Revenue (USD Billion) and Forecast By Application, 2018-2030

9.4. North America PEST Analysis

CHAPTER 10. Europe Injectable Drug Delivery Technology Market By Country

10.1. Europe Injectable Drug Delivery Technology Market Overview

10.2. U.K.

10.2.1. U.K. Injectable Drug Delivery Technology Revenue (USD Billion) and Forecast By Formulation, 2018-2030

10.2.2. U.K. Injectable Drug Delivery Technology Revenue (USD Billion) and Forecast By Device Type, 2018-2030

10.2.3. U.K. Injectable Drug Delivery Technology Revenue (USD Billion) and Forecast By Mode Of Delivery, 2018-2030

10.2.4. U.K. Injectable Drug Delivery Technology Revenue (USD Billion) and Forecast By Application, 2018-2030

10.3. Germany

10.3.1. Germany Injectable Drug Delivery Technology Revenue (USD Billion) and Forecast By Formulation, 2018-2030

10.3.2. Germany Injectable Drug Delivery Technology Revenue (USD Billion) and Forecast By Device Type, 2018-2030

10.3.3. Germany Injectable Drug Delivery Technology Revenue (USD Billion) and Forecast By Mode Of Delivery, 2018-2030

10.3.4. Germany Injectable Drug Delivery Technology Revenue (USD Billion) and Forecast By Application, 2018-2030

10.4. France

10.4.1. France Injectable Drug Delivery Technology Revenue (USD Billion) and Forecast By Formulation, 2018-2030

10.4.2. France Injectable Drug Delivery Technology Revenue (USD Billion) and Forecast By Device Type, 2018-2030

10.4.3. France Injectable Drug Delivery Technology Revenue (USD Billion) and Forecast By Mode Of Delivery, 2018-2030

10.4.4. France Injectable Drug Delivery Technology Revenue (USD Billion) and Forecast By Application, 2018-2030

10.5. Spain

10.5.1. Spain Injectable Drug Delivery Technology Revenue (USD Billion) and Forecast By Formulation, 2018-2030

10.5.2. Spain Injectable Drug Delivery Technology Revenue (USD Billion) and Forecast By Device Type, 2018-2030

10.5.3. Spain Injectable Drug Delivery Technology Revenue (USD Billion) and Forecast By Mode Of Delivery, 2018-2030

10.5.4. Spain Injectable Drug Delivery Technology Revenue (USD Billion) and Forecast By Application, 2018-2030

10.6. Rest of Europe

10.6.1. Rest of Europe Injectable Drug Delivery Technology Revenue (USD Billion) and Forecast By Formulation, 2018-2030

10.6.2. Rest of Europe Injectable Drug Delivery Technology Revenue (USD Billion) and Forecast By Device Type, 2018-2030

10.6.3. Rest of Europe Injectable Drug Delivery Technology Revenue (USD Billion) and Forecast By Mode Of Delivery, 2018-2030

10.6.4. Rest of Europe Injectable Drug Delivery Technology Revenue (USD Billion) and Forecast By Application, 2018-2030

10.7. Europe PEST Analysis

CHAPTER 11. Asia Pacific Injectable Drug Delivery Technology Market By Country

11.1. Asia Pacific Injectable Drug Delivery Technology Market Overview

11.2. China

11.2.1. China Injectable Drug Delivery Technology Revenue (USD Billion) and Forecast By Formulation, 2018-2030

11.2.2. China Injectable Drug Delivery Technology Revenue (USD Billion) and Forecast By Device Type, 2018-2030

11.2.3. China Injectable Drug Delivery Technology Revenue (USD Billion) and Forecast By Mode Of Delivery, 2018-2030

11.2.4. China Injectable Drug Delivery Technology Revenue (USD Billion) and Forecast By Application, 2018-2030

11.3. Japan

11.3.1. Japan Injectable Drug Delivery Technology Revenue (USD Billion) and Forecast By Formulation, 2018-2030

11.3.2. Japan Injectable Drug Delivery Technology Revenue (USD Billion) and Forecast By Device Type, 2018-2030

11.3.3. Japan Injectable Drug Delivery Technology Revenue (USD Billion) and Forecast By Mode Of Delivery, 2018-2030

11.3.4. Japan Injectable Drug Delivery Technology Revenue (USD Billion) and Forecast By Application, 2018-2030

11.4. India

11.4.1. India Injectable Drug Delivery Technology Revenue (USD Billion) and Forecast By Formulation, 2018-2030

11.4.2. India Injectable Drug Delivery Technology Revenue (USD Billion) and Forecast By Device Type, 2018-2030

11.4.3. India Injectable Drug Delivery Technology Revenue (USD Billion) and Forecast By Mode Of Delivery, 2018-2030

11.4.4. India Injectable Drug Delivery Technology Revenue (USD Billion) and Forecast By Application, 2018-2030

11.5. Australia

11.5.1. Australia Injectable Drug Delivery Technology Revenue (USD Billion) and Forecast By Formulation, 2018-2030

11.5.2. Australia Injectable Drug Delivery Technology Revenue (USD Billion) and Forecast By Device Type, 2018-2030

11.5.3. Australia Injectable Drug Delivery Technology Revenue (USD Billion) and Forecast By Mode Of Delivery, 2018-2030

11.5.4. Australia Injectable Drug Delivery Technology Revenue (USD Billion) and Forecast By Application, 2018-2030

11.6. South Korea

11.6.1. South Korea Injectable Drug Delivery Technology Revenue (USD Billion) and Forecast By Formulation, 2018-2030

11.6.2. South Korea Injectable Drug Delivery Technology Revenue (USD Billion) and Forecast By Device Type, 2018-2030

11.6.3. South Korea Injectable Drug Delivery Technology Revenue (USD Billion) and Forecast By Mode Of Delivery, 2018-2030

11.6.4. South Korea Injectable Drug Delivery Technology Revenue (USD Billion) and Forecast By Application, 2018-2030

11.7. Rest of Asia-Pacific

11.7.1. Rest of Asia-Pacific Injectable Drug Delivery Technology Revenue (USD Billion) and Forecast By Formulation, 2018-2030

11.7.2. Rest of Asia-Pacific Injectable Drug Delivery Technology Revenue (USD Billion) and Forecast By Device Type, 2018-2030

11.7.3. Rest of Asia-Pacific Injectable Drug Delivery Technology Revenue (USD Billion) and Forecast By Mode Of Delivery, 2018-2030

11.7.4. Rest of Asia-Pacific Injectable Drug Delivery Technology Revenue (USD Billion) and Forecast By Application, 2018-2030

11.8. Asia Pacific PEST Analysis

CHAPTER 12. Latin America Injectable Drug Delivery Technology Market By Country

12.1. Latin America Injectable Drug Delivery Technology Market Overview

12.2. Brazil

12.2.1. Brazil Injectable Drug Delivery Technology Revenue (USD Billion) and Forecast By Formulation, 2018-2030

12.2.2. Brazil Injectable Drug Delivery Technology Revenue (USD Billion) and Forecast By Device Type, 2018-2030

12.2.3. Brazil Injectable Drug Delivery Technology Revenue (USD Billion) and Forecast By Mode Of Delivery, 2018-2030

12.2.4. Brazil Injectable Drug Delivery Technology Revenue (USD Billion) and Forecast By Application, 2018-2030

12.3. Mexico

12.3.1. Mexico Injectable Drug Delivery Technology Revenue (USD Billion) and Forecast By Formulation, 2018-2030

12.3.2. Mexico Injectable Drug Delivery Technology Revenue (USD Billion) and Forecast By Device Type, 2018-2030

12.3.3. Mexico Injectable Drug Delivery Technology Revenue (USD Billion) and Forecast By Mode Of Delivery, 2018-2030

12.3.4. Mexico Injectable Drug Delivery Technology Revenue (USD Billion) and Forecast By Application, 2018-2030

12.4. Rest of Latin America

12.4.1. Rest of Latin America Injectable Drug Delivery Technology Revenue (USD Billion) and Forecast By Formulation, 2018-2030

12.4.2. Rest of Latin America Injectable Drug Delivery Technology Revenue (USD Billion) and Forecast By Device Type, 2018-2030

12.4.3. Rest of Latin America Injectable Drug Delivery Technology Revenue (USD Billion) and Forecast By Mode Of Delivery, 2018-2030

12.4.4. Rest of Latin America Injectable Drug Delivery Technology Revenue (USD Billion) and Forecast By Application, 2018-2030

12.5. Latin America PEST Analysis

CHAPTER 13. Middle East & Africa Injectable Drug Delivery Technology Market By Country 

13.1. Middle East & Africa Injectable Drug Delivery Technology Market Overview

13.2. GCC

13.2.1. GCC Injectable Drug Delivery Technology Revenue (USD Billion) and Forecast By Formulation, 2018-2030

13.2.2. GCC Injectable Drug Delivery Technology Revenue (USD Billion) and Forecast By Device Type, 2018-2030

13.2.3. GCC Injectable Drug Delivery Technology Revenue (USD Billion) and Forecast By Mode Of Delivery, 2018-2030

13.2.4. GCC Injectable Drug Delivery Technology Revenue (USD Billion) and Forecast By Application, 2018-2030

13.3. South Africa

13.3.1. South Africa Injectable Drug Delivery Technology Revenue (USD Billion) and Forecast By Formulation, 2018-2030

13.3.2. South Africa Injectable Drug Delivery Technology Revenue (USD Billion) and Forecast By Device Type, 2018-2030

13.3.3. South Africa Injectable Drug Delivery Technology Revenue (USD Billion) and Forecast By Mode Of Delivery, 2018-2030

13.3.4. South Africa Injectable Drug Delivery Technology Revenue (USD Billion) and Forecast By Application, 2018-2030

13.4. Rest of Middle East & Africa

13.4.1. Rest of Middle East & Africa Injectable Drug Delivery Technology Revenue (USD Billion) and Forecast By Formulation, 2018-2030

13.4.2. Rest of Middle East & Africa Injectable Drug Delivery Technology Revenue (USD Billion) and Forecast By Device Type, 2018-2030

13.4.3. Rest of Middle East & Africa Injectable Drug Delivery Technology Revenue (USD Billion) and Forecast By Mode Of Delivery, 2018-2030

13.4.4. Rest of Middle East & Africa Injectable Drug Delivery Technology Revenue (USD Billion) and Forecast By Application, 2018-2030

13.5. Middle East & Africa PEST Analysis

CHAPTER 14. Player Analysis Of Injectable Drug Delivery Technology Market

14.1. Injectable Drug Delivery Technology Market Company Share Analysis

14.2. Competition Matrix

14.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment

14.2.2. New Product Launches and Product Enhancements

14.2.3. Mergers And Acquisition In Global Injectable Drug Delivery Technology Market

14.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements

CHAPTER 15. Company Profile

15.1. B. Braun Melsungen

15.1.1. Company Snapshot

15.1.2. Business Overview

15.1.3. Financial Overview

15.1.3.1. Revenue (USD Billion), 2021

15.1.3.2. B. Braun Melsungen 2021 Injectable Drug Delivery Technology Business Regional Distribution

15.1.4. Product/Service and Specification

15.1.5. Recent Developments & Business Strategy

15.1.6. Manufacturing Plant Footprint Analysis

15.2. Baxter International, Inc.

15.3. Becton, Dickinson and Company

15.4. Bespak

15.5. Eli Lilly and Company

15.6. Gerresheimer

15.7. Pfizer Inc.

15.8. Sandoz

15.9. Schott AG

15.10. Terumo

15.11. Teva Pharmaceuticals Industries Ltd.

15.12. Ypsomed AG